Keywords: genta, begins, trials, novel, oral, taxane, biopharmaceutical

Genta begins trials for novel oral taxane

Article | 19 January 2009

Print This

Genta, a US biopharmaceutical company focused on delivering innovative products for the treatment of cancer, has initiated a new clinical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in